4th Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$159,966
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

NIH; FDA

LobbyistCovered position, as disclosed
LAUREN LATTANY New Assistant Director of Congressional Affairs
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); White House Office; Office of Management & Budget (OMB); SENATE; Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC)

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
LAUREN LATTANY New Assistant Director of Congressional Affairs
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: SENATE; Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); White House Office; Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Government Accountability Office (GAO)

Taxation/Internal Revenue Code TAX

Health Savings Accounts; Primary Care Enhancement Act

LobbyistCovered position, as disclosed
LAUREN LATTANY New Assistant Director of Congressional Affairs
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: White House Office; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO)

Health Issues HCR

American Health Care Act; Better Care Reconciliation Act; Patient Choice & Quality Care Act; Medicare Physician Payment Reform; Physician Workforce

LobbyistCovered position, as disclosed
LAUREN LATTANY New Assistant Director of Congressional Affairs
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); White House Office; Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Executive Office of the President (EOP)

Medicare/Medicaid MMM

Graduate Medical Education; Resident Physician Shortage Act; Independent Payment Advisory Board (IPAB)

LobbyistCovered position, as disclosed
LAUREN LATTANY New Assistant Director of Congressional Affairs
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA)

Budget/Appropriations BUD

National Health Service Corps; Community Health Centers; Health Resource & Services Administration

LobbyistCovered position, as disclosed
LAUREN LATTANY New Assistant Director of Congressional Affairs
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office; Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Office of Management & Budget (OMB)

Insurance INS

American Health Care Act; Better Care Reconciliation Act; Professional Liability Insurance; Health Insurance

LobbyistCovered position, as disclosed
LAUREN LATTANY New Assistant Director of Congressional Affairs
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Government Accountability Office (GAO); SENATE; Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; White House Office

Education EDU

Teaching Health Center Graduate Medical Education; National Health Service Corps; Foreign Medical School Accountability Fairness Act; Single Accreditation

LobbyistCovered position, as disclosed
LAUREN LATTANY New Assistant Director of Congressional Affairs
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; White House Office; Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); SENATE; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA)

Torts TOR

Medical Liability Reform; Protecting Access to Care Act; Good Samaritan Health Professionals Act

LobbyistCovered position, as disclosed
LAUREN LATTANY New Assistant Director of Congressional Affairs
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); White House Office; Executive Office of the President (EOP); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Government Accountability Office (GAO); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.